IPharma TIRZEPSEMA 34mg Compound peptide Pen- 34mg 1.8ml
Weight Management • Appetite Control • Metabolic Support
Advanced Combination Therapy: 30mg Tirzepatide + 4mg Semaglutide
The iPharma TirzepSema 34mg Pen represents the pinnacle of peptide therapy, blending two of the most effective GLP-1 receptor agonists into a single, high-performance weekly injection. This dual-action formula is engineered for clients who require a stronger, more synergistic approach to weight management, offering deeper appetite suppression, smoother metabolic control, and faster fat-loss results than single-ingredient therapies alone.
Key Benefits
- Reduces appetite & Increases Satiety: Helps you feel full with less food.
- Improves Blood Sugar Control: Stabilizes glucose levels and insulin response.
- Reduces Cravings: Targets the psychological drive to eat.
- Enhances Metabolic Health: Improves overall metabolic function.
- Significant Weight Loss: Supports substantial, weekly weight reduction.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.